Q2 2025 LifeStance Health Group Inc Earnings Call Transcript
Key Points
- LifeStance Health Group Inc (LFST) achieved double-digit organic revenue growth and 10% adjusted EBITDA margins in Q2 2025.
- The company raised its full-year guidance for adjusted EBITDA, expecting to achieve double-digit margins for the full year.
- LifeStance Health Group Inc (LFST) delivered exceptionally strong free cash flow of $57 million, the highest in its history.
- The clinician base grew by 173 clinicians in the quarter, reaching a total of 7,780, indicating strong recruitment and retention.
- The company is leveraging AI and digital solutions to improve operational efficiency, clinician satisfaction, and patient engagement.
- Total revenue per visit decreased by 1% year-over-year due to a single outlier payer dynamic.
- Despite strong cash flow in Q2, the company expects a significant decrease in Q3 due to factors like 401(k) match and higher CapEx.
- The competitive environment for recruiting and retaining clinicians remains challenging.
- The company faces potential headwinds from evolving state-level legislation around the use of AI in therapy sessions.
- LifeStance Health Group Inc (LFST) has limited exposure to government payers, which could be a risk if there are changes in reimbursement policies.
Hello, and welcome to the LifeStance Health second-quarter 2025 earnings conference call. (Operator Instructions)
Now I would like to turn the call over to Monica Prokocki. You may begin.
Thank you, operator. Good morning, everyone, and welcome to LifeStance Health's second quarter 2025 earnings conference call. I'm Monica Prokocki, Vice President of Finance and Investor Relations.
Joining me today are Dave Bourdon, Chief Executive Officer; and Ryan McGroarty, Chief Financial Officer. Ken Burdick, our Executive Chairman, is also with us.
We issued the earnings release and presentation before the market opened this morning. Both are available on the Investor Relations section of our website, investor.lifestance.com. In addition, a replay will be available following the call.
Before turning over to management for their prepared remarks, please direct your attention to the disclaimers about forward-looking statements included in the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
